title: Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents.
abstract: BACKGROUND
  Stent thrombosis (ST) following the implantation of drug-eluting stents (DES) remains the major limitation of this new technology. The identification of modifiable correlates of ST may help reduce this catastrophic event.
  
  
  METHODS
  This was a retrospective, single-center, lesion-based study. A cohort of 45 consecutive lesions (35 patients) initially treated with successful DES implantation from May 2003 to February 2005 that re-presented with ST within 12 months was identified. This cohort was compared to a control group of 1,620 unselected lesions (1,187 patients) that were successfully treated with DES implantation and which remained free of ST. Comparison of angiographic and procedural features was made between the ST and no-ST groups, and logistic regression analysis was then performed to identify independent correlates of ST. For the purposes of the study only definite ST events (angiographically or autopsy proven) were considered.
  
  
  RESULTS
  Independent angiographic predictors of cumulative ST at 12 months were left anterior descending (LAD) artery (OR: 1.91, CI: 1.01-3.59, P = 0.045), bifurcation (OR: 2.43, CI: 1.06-5.56, P = 0.035), and in-stent restenotic (OR: 2.64, CI: 1.12-6.25, P = 0.027) lesions. Procedural predictors were number of stents per lesion (OR: 2.30, CI: 1.29-4.11, P = 0.005) and intravascular ultrasound (IVUS) guidance (OR: 0.45, CI: 0.24-0.84, P = 0.013). Correlates of subacute events were LAD artery, proximal segment, and lack of IVUS guidance. Correlates of late ST were bifurcation and in-stent restenotic lesions.
  
  
  CONCLUSIONS
  Angiographic and procedural correlates of subacute and late ST after DES implantation differ. Lack of IVUS guidance was the only modifiable predictor identified. Treatment of bifurcation and restenotic lesions was predictive of late events.
authors: Division of Cardiology, Washington Hospital Center, Washington, DC 20010, USA.
authors: Probal
authors: P
authors: Roy
authors: Rebecca
authors: R
authors: Torguson
authors: Teruo
authors: T
authors: Okabe
authors: Tina L
authors: TL
authors: Pinto Slottow
authors: Daniel H
authors: DH
authors: Steinberg
authors: Kimberly
authors: K
authors: Smith
authors: Zhenyi
authors: Z
authors: Xue
authors: Lowell F
authors: LF
authors: Satler
authors: Augusto D
authors: AD
authors: Pichard
authors: Ron
authors: R
authors: Waksman
mesh_terms: D000077144:Clopidogrel; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000503:physiopathology / Q000517:prevention & control*; D003328:Coronary Thrombosis / Q000503:physiopathology / Q000517:prevention & control*; D054855:Drug-Eluting Stents; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000960:Hypolipidemic Agents; D006493:Heparin; D000077144:Clopidogrel; D013988:Ticlopidine